tirzepatide decision today ✨ 𝐓𝐡𝐢𝐬 𝐖𝐞𝐞𝐤'𝐬 𝐌𝐮𝐬𝐭-𝐑𝐞𝐚𝐝 𝐢𝐧 𝐎𝐮𝐫 𝐍𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 ✨ We're breaking down one of the biggest conversations in medical weight loss right now: vs Oral Semaglutide and what actually matters when choosing Tirzepatide Supply Crisis Averted: FDA

Current clinical evidence from a meta-analysis of phase 2 and three studies of tirzepatide in participants with T2D indicates that tirzepatide treatment is not associated with an increased risk of MACE-4, a composite outcome comprising the four outcomes cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization due to unstable angina (HR = 0.80

Furthermore, patients were categorized by previous (within 6 months) GLP-1 RA use to include both populations and account for the potential confounding of outcomes

SeekPeptides members gain access to protocol tracking tools and detailed escalation guides that account for individual variation, making it easier to find the dose that delivers results without unnecessary discomfort

Everyone is so nice and funny

Mazdutide is another newer option, and the mazdutide versus tirzepatide comparison covers the differences in mechanism and early efficacy data